FDA Inspection 1044159 — AGC Biologics GmbH
The FDA completed an inspection of AGC Biologics GmbH on Feb 6, 2018 in Heidelberg. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 6, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Heidelberg (Germany)